CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 6 enrolled
Drug / intervention
Argus 16 Retinal Stimulation Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00279500
NCT00279500N/ACompleted
CompareCT.gov

Chronic Retinal Electrodes to Provide Electrical Stimulation of the Retina to Elicit Visual Percepts in Blind Subjects

Second Sight Medical Products·interventional·Posted Jan 19, 2006·Updated Apr 12, 2023

In Brief

A clinical study evaluating Argus 16 Retinal Stimulation System for Retinitis Pigmentosa. Completed, enrolled 6 participants across 1 site.

Detailed Summary

The objective of this study is to evaluate the safety and efficacy of the retinal stimulation system by evaluating the data after chronic implantation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRetinitis Pigmentosa
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 19, 2006
Enrollment StartFeb 27, 2002
Primary CompletionDec 31, 2014
TodayJul 2, 2026
Enrollment to primary: 12.8 yearsPosted 20.5 years ago

Interventions

Argus 16 Retinal Stimulation Systemdevice

The chronic retinal stimulation system is an implantable electronic device designed to provide electrical stimulation of the retina in order to elicit visual percepts in blind subjects.